Farmas USA

Son tres contra una!

A generic version of Lovaza has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Lovaza and have been approved by the FDA:

omega-3-acid ethyl esters capsule;oral

Manufacturer: APOTEX INC
Approval date: September 30, 2014
Strength(s): 1GM CONTAINS AT LEAST 900MG OF THE ETHYL ESTERS OF OMEGA-3 FATTY ACIDS [AB]
Manufacturer: PAR PHARM INC
Approval date: June 24, 2014
Strength(s): 1GM CONTAINS AT LEAST 900MG OF THE ETHYL ESTERS OF OMEGA-3 FATTY ACIDS [AB]
Manufacturer: TEVA PHARMS USA
Approval date: April 7, 2014
Strength(s): 1GM CONTAINS AT LEAST 900MG OF THE ETHYL ESTERS OF OMEGA-3 FATTY ACIDS [AB]

pero al final el producto farmacéutico mejor y de mayor calidad es el de AMRN, no?

a este ritmo, sin efecto kowa, los 14k/semana para Junio :(

AMRN

OXGN

Artículo alcista en SA, por todo lo que ya sabemos y su infravaloración.

http://seekingalpha.com/article/2677775-oxigene-why-i-think-this-risky-biotech-is-a-speculative-buy

De todas todas. Pero ... vale tanto lo que tienes y sabes como a que arbol te arrimas ... 

ISCO

The company reported ($0.01) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.01)

thld

parece que acusa efecto brean, una casa importante por el momento soportando en fibonacci de la subida desde minimos 38,2%

OXGN

Pero sigue bajando!!, que acabe ya esta semana para ella porque ha sido un no parar de caer